Form 8.3 - Life Science REIT Public Limited Company
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 01 2025
0mins
Source: Globenewswire
Key Information
- Discloser: Rathbones Group Plc is the entity making the disclosure regarding its interests in relevant securities.
- Offeror/Offeree: The disclosure pertains to Life Science REIT Plc.
- Date of Position: The position was held as of August 29, 2025.
- Other Disclosures: Rathbones is not making disclosures for any other parties involved in the offer.
Positions Held
- Interests in Relevant Securities: Rathbones Group Plc holds 48,759,992 shares, representing 13.93% of the relevant securities of Life Science REIT Plc.
- Short Positions: There are no short positions disclosed.
Dealings
- Recent Transactions: Rathbones sold 7,700 ordinary shares at a price of 38.21p per share.
Other Information
- Indemnity and Arrangements: There are no indemnity or option arrangements related to the relevant securities.
- Agreements on Voting Rights: No agreements or understandings regarding voting rights or future acquisitions/disposals of relevant securities have been disclosed.
- Supplemental Form: No Supplemental Form 8 (Open Positions) is attached to this disclosure.
Contact Information
- Disclosure Date: The disclosure was made on September 1, 2025.
- Contact Person: Callum Ridley from the Compliance Department can be reached at 0151 243 7037 for further inquiries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
